Medication info
Selmistar Tablet 40/10 mg

Selmistar Tablet 40/10 mg

Prescription medication경구
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
(주)셀트리온제약
Appearance
This is a biconvex oval double tablet that is white and light gray.
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201605775 · Approved 2016.09.30 · Insurance code 693902370

Summary

Main use
Improvement of blood pressure control in essential hypertension.
Who takes it
Adults · Children
Adult dose
The recommended dosage for this medication is 1 tablet once a day, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with renal impairment, no dosage adjustment is necessary for mild and moderate renal impairment; however, for severe renal impairment, it is recommended to start at a lower dosage and gradually increase it. For patients with liver impairment, the recommended daily dosage of telmisartan should not exceed
Child dose
Safety and efficacy for pediatric patients under 18 years of age have not been established, so administration of this medication is not recommended.

Ingredients

Manufacturer
(주)셀트리온제약

Efficacy & effects

Improvement of blood pressure control in essential hypertension.

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or telmisartan.

How to take

Adult dose

The recommended dosage for this medication is 1 tablet once a day, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients with renal impairment, no dosage adjustment is necessary for mild and moderate renal impairment; however, for severe renal impairment, it is recommended to start at a lower dosage and gradually increase it. For patients with liver impairment, the recommended daily dosage of telmisartan should not exceed

Child dose

Safety and efficacy for pediatric patients under 18 years of age have not been established, so administration of this medication is not recommended.

Precautions

This medication may pose a serious risk to the fetus, especially during the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. Individuals with allergies to any of the components of this medication, specific heart diseases, liver disorders, or severe hypotension should not take it. Caution is advised for patients with liver or kidney dysfunction, gastrointestinal diseases, and elderly patients. Side effects such as dizziness, edema, and hypotension may occur during use, and immediate consultation with medical personnel is required in severe cases. This medication may interact with other drugs, so inform your healthcare provider of any medications you are currently taking. Women who are pregnant or breastfeeding should not take this medication, and those planning to become pregnant should consult with healthcare providers before use. It is not recommended for children or adolescents under 18 years of age as safety and efficacy have not been sufficiently established. Overdosage can result in hypotension, dizziness, and cardiac issues, requiring immediate hospital treatment. Store this medication out of reach of children and take it rapidly after opening; it is advised not to transfer it to another container.

Side effects and when to seek care immediately

Serious side effects

Urticaria, severe swelling (edema), angioedema, chest discomfort, difficulty breathing, anaphylaxis, angioedema (potentially fatal), Stevens-Johnson syndrome, severe skin adverse reactions, severe allergic reactions, myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, hypotension, syncope, severe edema or urinary abnormalities, hepatitis, jaundice, elevated liver enzymes, liver abnormalities (jaundice), intestinal vascular edema, severe neurological symptoms (cerebral infarction

Mild side effects

  • Dizziness
  • peripheral edema
  • upper respiratory infection
  • urinary tract infection
  • anemia
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
Show 26 more
  • insomnia
  • mood changes
  • anxiety
  • confusion
  • drowsiness
  • migraine
  • headache
  • sensory disturbance
  • fainting
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal symptoms
  • muscle rigidity
  • visual disturbance
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • flushing
  • hypotension
  • orthostatic hypotension
  • cough
  • abdominal pain
  • dyspepsia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that is shielded from light and air, at a temperature between 1°C and 30°C at room temperature. Following these storage conditions helps maintain the drug's efficacy and prevents degradation.

Appearance and packaging

Appearance

This is a biconvex oval double tablet that is white and light gray.

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.